Study

EORTC-1748-QLG-BCG-LYMG-GCG-GUCG

Phase 1-3 development of an EORTC module assessing fertility issues and patient care needs

Study documentation Back to result

Trial Status

Closed to Patient Entry

Dates

Date of activation: 01-Nov-2019

Data management at EORTC

None

Design

QoL Mod. development
Not randomized / N.A.

Targeted Sample size

Treatment

None

Study Staff

  • Joachim Weis (Study Coordinator), Universitaetsklinikum Freiburg, Freiburg
  • Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels

Type of cancer

Participating groups

  • EORTC Breast Cancer Group
  • EORTC Genito-Urinary Cancers Group
  • EORTC Gynecological Cancer Group
  • EORTC Lymphoma Group
  • EORTC Quality of Life Group
  • European Society for Gynecological Oncology

Protocol summary

http://clinicaltrials.gov/study/

NCT number